Industrial Pharmacy Section Annual Report 2009-2010
Founded in 1955, FIP's Industrial Pharmacy Section has expanded to a worldwide industrial pharmacy network with many activities. IPS strives to spread its activities across the different regions, involving both participants and organizations from developing and developed countries. IPS has a special focus on young pharmacists and students, and encourages their interest in the pharmaceutical industry. IPS is among the top three largest sections within FIP, with 486 members.
Currently, IPS activities have an emphasis on the quality of medicines. However, other topics such as clinical trials, pharmacy education and orphan drugs have been the subject of recent events. To this end IPS frequently co-operates with other sections in the BPP; with special interest groups in the BPS; and with outside parties including national and (supra-) regional industry associations, scientific and professional societies (e.g. ISPE, AAPS, RPSGB, EUFEPS), and health regulatory agencies and inspectorates (EMEA, FDA).
Mission
The mission of the Industrial Pharmacy Section is to represent and serve the pharmaceutical profession and pharmaceutical sciences within the pharmaceutical industry worldwide.
Accomplishments
IPS has maintained its member benefit plan, consisting of reduced fees to IPS sponsored events, subscription to the quarterly IPS Newsletter (full colour), and subscription to the journal Industrial Pharmacy (regular price 85 € per year). For the PharmaBridge Project, Prof. M.H. Anisfeld has been actively involved on behalf of IPS.
Furthermore, IPS has presented at various conferences worldwide, thereby promoting FIP. Representation of IPS and FIP at international conferences:
• 10th International Forum on Pharmacy held in Ivory Coast on the 3-6 of June 2009.
• 4th annual conference for The South African Association of Pharmacists in Industry held in Pretoria on the 22-23 July 2009. Speakers from IPS: Dr A.P. Sam and Prof M.A. Anisfeld
• Dutch Medicines Days - Developing groundbreaking new treatments for Gene and Cell Therapy and Tissue Engineering, 13 October 2009. IPS-representative: Dr A.P. Sam
• Tablet Manufacturing Technologies - International Industrial Pharmacy Course at King Saud University, Riyadh, KSA 20-21 October 2009. IPS representatives Dr Fars Alanazi and Dr Adel Sakr
• Tablet Workshop, January 2010, Cairo, Egypt, Dr. A.P. Sam and Dr Adel Sakr
Two IPS Awards were granted during the FIP Istanbul Congress. The IPS Medal Award was given to Director Per From from Sweden, to recognize his outstanding contribution to pharmaceutical science and practice within industry. The Mike How Award was given to Mr. Ram Malis from Israel, to recognize and stimulate his keen interest and passion for the Industrial Pharmacy sector.
Projects
The Working Group on Tablet Tooling met in January 2010 in Basel. The WG is chaired by Dr. AP. Sam and focuses on the technical problems of sticking during tablet production. The WG consists of representatives from academia and industry.
Activities in line with BPP Strategy Plan
IPS is supporting the BPP strategy by being actively involved in the following FIP Committees:
FIP Pediatric Working Group, IPS representative Dr Linda Hakes
FIP BPP BPS Ad Hoc Working Group, IPS representative Henriette Feiertag
